Published in Philos Trans R Soc Lond B Biol Sci on August 12, 2011
Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease. Proc Natl Acad Sci U S A (2012) 1.15
Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing. J Am Coll Cardiol (2014) 1.08
Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS One (2012) 1.05
Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol (2015) 1.00
Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci (2012) 0.96
Cellular reprogramming: recent advances in modeling neurological diseases. J Neurosci (2011) 0.92
Induced pluripotent stem cells to model and treat neurogenetic disorders. Neural Plast (2012) 0.88
Bioreactor engineering of stem cell environments. Biotechnol Adv (2013) 0.88
Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases. Mol Neurobiol (2014) 0.85
Modelling human disease with pluripotent stem cells. Curr Gene Ther (2013) 0.83
Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering. Regen Med Res (2013) 0.82
The evolving biology of cell reprogramming. Philos Trans R Soc Lond B Biol Sci (2011) 0.81
Neurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discovery. Neurol Sci (2014) 0.80
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Viable offspring derived from fetal and adult mammalian cells. Nature (1997) 22.46
Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (2009) 20.49
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell (2006) 11.38
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell (2009) 10.52
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol (2007) 9.23
Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med (2010) 9.19
Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature (1998) 8.42
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature (2010) 7.05
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature (2009) 7.04
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci (2009) 5.58
Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature (2007) 5.56
Retracted Generation of pluripotent stem cells from adult human testis. Nature (2008) 5.49
Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell (1993) 5.12
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 4.38
Generation of pluripotent stem cells from neonatal mouse testis. Cell (2004) 3.95
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell (2010) 3.82
Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell (2009) 3.80
Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol (2007) 3.48
Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science (2001) 3.44
Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell (2007) 3.41
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet (2001) 3.27
A role for the elongator complex in zygotic paternal genome demethylation. Nature (2010) 3.27
L1 retrotransposition in neurons is modulated by MeCP2. Nature (2010) 3.25
Dogs cloned from adult somatic cells. Nature (2005) 3.24
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature (2007) 3.01
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet (2001) 2.67
Female human iPSCs retain an inactive X chromosome. Cell Stem Cell (2010) 2.59
Parthenogenetic stem cells in nonhuman primates. Science (2002) 2.54
Elevated levels of two tRNA species bypass the requirement for elongator complex in transcription and exocytosis. Mol Cell (2006) 2.22
Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (2004) 2.07
Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc (2010) 2.05
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell (2006) 2.02
Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol Ther (2010) 1.99
Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature. Medicine (Baltimore) (1970) 1.89
Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol (2000) 1.89
Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia. J Neurol Sci (1978) 1.87
Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell (2010) 1.81
Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat Biotechnol (1998) 1.77
Elongator complex: how many roles does it play? Curr Opin Cell Biol (2007) 1.71
Elp1p, the yeast homolog of the FD disease syndrome protein, negatively regulates exocytosis independently of transcriptional elongation. Mol Cell (2005) 1.64
The cellular function of MASH1 in autonomic neurogenesis. Neuron (1995) 1.62
Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet (2004) 1.58
A cat cloned by nuclear transplantation. Nature (2002) 1.51
Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia. J Neurol Sci (1978) 1.51
Central autonomic dysfunction with defective lacrimation; report of five cases. Pediatrics (1949) 1.44
Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod (2005) 1.44
Familial dysautonomia. Muscle Nerve (2004) 1.40
Loss of mouse Ikbkap, a subunit of elongator, leads to transcriptional deficits and embryonic lethality that can be rescued by human IKBKAP. Mol Cell Biol (2008) 1.35
Trophic functions of the neuron. V. Familial dysautonomis. Current concepts of dysautonomia: neuropathological defects. Ann N Y Acad Sci (1974) 1.31
Human ESC-derived neural rosettes and neural stem cell progression. Cold Spring Harb Symp Quant Biol (2009) 1.28
EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochem Biophys Res Commun (2003) 1.28
Pregnancy: a cloned horse born to its dam twin. Nature (2003) 1.25
Quantitative studies of ciliary and sphenopalatine ganglia in familial dysautonomia. J Neurol Sci (1978) 1.25
Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem Biophys Res Commun (2003) 1.19
Familial dysautonomia: a review of the current pharmacological treatments. Expert Opin Pharmacother (2005) 1.15
Induced pluripotent stem cell technology for the study of human disease. Nat Methods (2010) 1.09
A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect. Genomics (2007) 1.08
Altered nerve growth factor in fibroblasts from patients with familial dysautonomia. Proc Natl Acad Sci U S A (1980) 1.05
Kinetin in familial dysautonomia carriers: implications for a new therapeutic strategy targeting mRNA splicing. Pediatr Res (2009) 1.00
Familial dysautonomia: detection of the IKBKAP IVS20(+6T --> C) and R696P mutations and frequencies among Ashkenazi Jews. Am J Med Genet (2002) 0.98
Tyrosine hydroxylase immunoreactivity in familial dysautonomia. Science (1979) 0.94
High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis. In Vitro Cell Dev Biol Anim (2010) 0.94
Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia. Hum Mutat (2007) 0.93
Identification of the first non-Jewish mutation in familial Dysautonomia. Am J Med Genet A (2003) 0.91
Human embryonic stem cells carrying mutations for severe genetic disorders. In Vitro Cell Dev Biol Anim (2010) 0.90
Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim (2010) 0.86
Personality development and familial dysautonomia. Pediatrics (1980) 0.85
Intellectual development and familial dysautonomia. Pediatrics (1979) 0.82
Normal mitochondrial DNA and respiratory chain activity in familial dysautonomia fibroblasts. Biochem Mol Med (1996) 0.81
Production of transgenic cloned piglets from genetically transformed fetal fibroblasts selected by green fluorescent protein. Theriogenology (2005) 0.81
When diseases disappear--the case of familial dysautonomia. N Engl J Med (2009) 0.79
Neuroscience: Excessive mobility interrupted. Nature (2010) 0.76
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature (2011) 7.90
Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2004) 7.51
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature (2009) 7.04
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev (2008) 5.34
Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol (2007) 3.48
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol (2003) 3.43
Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells (2007) 3.11
Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med (2005) 3.04
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell (2013) 2.74
Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med (2007) 2.61
Parthenogenetic stem cells in nonhuman primates. Science (2002) 2.54
Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol (2010) 2.54
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell (2013) 2.51
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol (2010) 2.43
miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell (2011) 2.33
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell (2013) 2.31
BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage. Stem Cells (2009) 2.22
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol (2012) 2.09
Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc (2010) 2.05
Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell (2010) 2.02
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nat Commun (2011) 1.84
A poised chromatin platform for TGF-β access to master regulators. Cell (2011) 1.81
High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell (2008) 1.79
Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat Biotechnol (2012) 1.74
Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells. Environ Health Perspect (2012) 1.70
Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol (2003) 1.64
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells (2005) 1.56
Production of green fluorescent protein transgenic embryonic stem cells using the GENSAT bacterial artificial chromosome library. Stem Cells (2006) 1.55
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev (2011) 1.55
Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat Biotechnol (2005) 1.54
Therapeutic cloning in individual parkinsonian mice. Nat Med (2008) 1.46
Cell fate plug and play: direct reprogramming and induced pluripotency. Cell (2011) 1.42
Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest (2012) 1.40
Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev (2009) 1.39
Prospective isolation of cortical interneuron precursors from mouse embryonic stem cells. J Neurosci (2010) 1.36
Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs. Cell Rep (2013) 1.36
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur J Neurosci (2006) 1.32
Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells. Cell Growth Differ (2002) 1.22
The expanding role of miR-302-367 in pluripotency and reprogramming. Cell Cycle (2012) 1.13
Induced pluripotent stem cell technology for the study of human disease. Nat Methods (2010) 1.09
Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain (2008) 1.06
Maturation of spinal motor neurons derived from human embryonic stem cells. PLoS One (2012) 1.04
ZFX controls the self-renewal of human embryonic stem cells. PLoS One (2012) 1.03
Making and repairing the mammalian brain--in vitro production of dopaminergic neurons. Semin Cell Dev Biol (2003) 1.02
Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J Neurochem (2003) 1.01
Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat Protoc (2012) 0.97
Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J Neurosci (2004) 0.96
Single-molecule analysis reveals changes in the DNA replication program for the POU5F1 locus upon human embryonic stem cell differentiation. Mol Cell Biol (2010) 0.92
Cellular reprogramming: recent advances in modeling neurological diseases. J Neurosci (2011) 0.92
Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J Neurochem (2007) 0.92
Embryonic stem cell-derived neurons form functional networks in vitro. Stem Cells (2006) 0.91
Converting human pluripotent stem cells to neural tissue and neurons to model neurodegeneration. Methods Mol Biol (2011) 0.91
Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Funct Integr Genomics (2005) 0.87
Protocols for generating ES cell-derived dopamine neurons. Adv Exp Med Biol (2009) 0.86
Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons. FASEB J (2006) 0.86
Dual-SMAD Inhibition/WNT Activation-Based Methods to Induce Neural Crest and Derivatives from Human Pluripotent Stem Cells. Methods Mol Biol (2016) 0.84
Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells (2006) 0.82
Mesenchymal cells. Methods Enzymol (2006) 0.81
Enhancement of polysialic acid expression improves function of embryonic stem-derived dopamine neuron grafts in Parkinsonian mice. Stem Cells Transl Med (2013) 0.79
Build-a-brain. Cell Stem Cell (2013) 0.78
Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells. Stem Cells Dev (2010) 0.78
Aging in iPS cells. Aging (Albany NY) (2014) 0.78
Enriched motor neuron populations derived from bacterial artificial chromosome-transgenic human embryonic stem cells. Clin Neurosurg (2009) 0.77
New ISSCR guidelines: clinical translation of stem cell research. Lancet (2016) 0.77
Neuroscience: Excessive mobility interrupted. Nature (2010) 0.76
IPSCs put to the test. Nat Biotechnol (2011) 0.75
Correction: Targeting Homologous Recombination in Notch-Driven C. elegans Stem Cell and Human Tumors. PLoS One (2016) 0.75
Too much Sonic, too few neurons. Nat Neurosci (2009) 0.75
815 Human Embryonic Stem Cells: In Vivo Behavior after Grafting in the Rodent Brain. Neurosurgery (2005) 0.75
Therapeutic Cloning in Mice 879. Neurosurgery (2006) 0.75